RCUS

Arcus Biosciences, Inc.

HealthcareBiotechnologyUSUSDPeers →

$25.84

LiveJun 22, 2026

Market cap

$2.6B

52w range

7.91 – 28.72

P / E

—

EPS

—

Volume

320.97K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Arcus Biosciences, Inc.’s valuation

Enterprise value

$2.36B

Market cap

$2.45B

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$2.45B

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$2.36B

Valuation

· key metrics · TTM

EV / EBITDA-7.1×

EV / Sales10.0×

EV / FCF-4.8×

Net debt / EBITDA0.3×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage